Full name
ACCUPHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
ACCUPHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. CHEŁMSKA 30/34, 00-725 WARSZAWA
TAX ID1132846846
Rate company:
ACCUPHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID1132846846
KRS0000395989
Share capital5,000.00 zł
address
UL. CHEŁMSKA 30/34, 00-725 WARSZAWA
Website
www.accupharma.plCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
1132846846
REGON
145489069
KRS
0000395989
Legal form
limited liability company
Register Address
UL. CHEŁMSKA 30/34, 00-725 WARSZAWA
Date of registration in KRS
2011-09-16
Date of commencement of economic activity
2011-09-16
Act signature
RDF/594186/24/378
Website
WWW.ACCUPHARMA.PL
Pkd codes
72.19.Z - Other research and experimental development on natural sciences and engineering
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
68.20.Z - Rental and operating of own or leased real estate
86.90.E - Other human health activities notelsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL68 1020 1169 0000 8102 0177 6624 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 1,3 | -0 | 0,1 | 1382,9 |
Gross profit (loss) | 1,3 | -0 | 0,1 | 1660,7 |
EBITDA | 1,3 | -0 | 0,1 | 1378,8 |
Short time liabilities | 3,2 | 3,2 | 3,2 | 0,5 |
Other operating costs | 0 | 0 | 0 | 1 770 200 |
Equity capital | 1,1 | 1,1 | 1,2 | 10 |
Operating profit (EBIT) | 1,3 | -0 | 0,1 | 1378,8 |
Assets | 8,9 | 8,9 | 9 | 1,4 |
Net profit (loss) | 1,3 | -0 | 0,1 | 1660,7 |
Cash | 0 | 0 | 0 | 15 |
Net income from sale | 1,6 | 0 | 0,1 | -∞ |
Liabilities and provisions for liabilities | 7,8 | 7,8 | 7,8 | 0,2 |
Working assets | 0 | 0 | 0,1 | 420,4 |
Other income costs | 0 | 0 | 0 | -100 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 122 | -0,6 | 9,1 | 9,7 |
Equity capital to total assets | 12,1 | 12 | 13 | 1 |
Gross profit margin | 82,5 | 88,8 | 6,3 | |
EBITDA Margin | 82,2 | 88,9 | 6,7 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 729 | 2 147 483 648 | 9753 | -2 147 473 895 |
Current financial liquidity indicator | 0.011809947900474072 | 0.009022949263453484 | 0.046741172671318054 | 0 |
Net dept to EBITDA | 4.379732608795166 | -691.4713745117188 | 54.20420837402344 | 745,7 |
Financial statements
01-01-2022 - 31-12-2022
Annual financial report
Download xml01-01-2022 - 31-12-2022
Resolution or decision approving the annual financial statements
Download pdf01-01-2022 - 31-12-2022
Resolution on profit distribution or loss coverage
Download pdfuses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
AGNIESZKA MAGDZIARZ CADENAS
Puławy
"HYD-REX"
Łódź